Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non‐small cell lung cancer
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Science"
DOI: 10.1111/cas.14711
Abstract: The standard treatment for locally advanced non‐small cell lung cancer (NSCLC) is chemoradiotherapy (CRT) followed by anti‐programmed cell death‐ligand 1 (anti‐PD‐L1) treatment. BIM deletion polymorphism induces the suppression of apoptosis resulting from epidermal growth factor… read more here.
Keywords: bim polymorphism; anti treatment; bim deletion; treatment ... See more keywords